PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
ALK-B.CO vs. GMAB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

ALK-B.CO vs. GMAB

Last updated Jun 5, 2026

ALK-B.CO (ALK-Abelló A/S) and GMAB (Genmab A/S) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, ALK-B.CO returned 15.94%/yr vs 2.55%/yr for GMAB. At a 0.21 correlation, their price movements are largely independent.

Performance

ALK-B.CO vs. GMAB - Performance Comparison

The chart below illustrates the hypothetical performance of a DKK 10,000 investment in ALK-Abelló A/S (ALK-B.CO) and Genmab A/S (GMAB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

ALK-B.CO is traded in DKK, while GMAB is traded in USD. To make them comparable, the GMAB values have been converted to DKK using the latest available exchange rates.

Returns By Period

In the year-to-date period, ALK-B.CO achieves a 17.33% return, which is significantly higher than GMAB's -16.71% return. Over the past 10 years, ALK-B.CO has outperformed GMAB with an annualized return of 15.94%, while GMAB has yielded a comparatively lower 2.55% annualized return.

ALK-B.CO

1D
1.53%
1M
3.26%
YTD
17.33%
6M
17.74%
1Y
46.73%
3Y*
48.44%
5Y*
14.30%
10Y*
15.94%

GMAB

1D
2.48%
1M
-8.04%
YTD
-16.71%
6M
-19.87%
1Y
14.75%
3Y*
-15.75%
5Y*
-8.21%
10Y*
2.55%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ALK-B.CO vs. GMAB - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
ALK-B.CO
ALK-Abelló A/S		17.33%43.68%57.21%5.36%-43.99%37.20%52.91%70.31%29.73%-19.14%
GMAB
Genmab A/S		-16.71%30.29%-30.10%-26.94%13.81%4.43%66.42%38.71%4.31%-12.24%

Correlation

The correlation between ALK-B.CO and GMAB is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.26

Correlation (3Y)
Calculated over the trailing 3-year period

0.19

Correlation (5Y)
Calculated over the trailing 5-year period

0.25

Correlation (10Y)
Calculated over the trailing 10-year period

0.26

Correlation (All Time)
Calculated using the full available price history since Jun 2, 2009

0.21

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

ALK-Abelló A/S

Genmab A/S

Often compared with ALK-B.CO:
ALK-B.CO vs. NVOALK-B.CO vs. MELIALK-B.CO vs. CEPUALK-B.CO vs. NOWALK-B.CO vs. NVDAALK-B.CO vs. ANETALK-B.CO vs. CPRX
Often compared with GMAB:
GMAB vs. EVVTYGMAB vs. YELPGMAB vs. SANMGMAB vs. CPRXGMAB vs. QQQGMAB vs. SCHGGMAB vs. SPY

Return for Risk

ALK-B.CO vs. GMAB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
ALK-B.CO
ALK-B.CO Risk / Return Rank: 8585
Overall Rank
ALK-B.CO Sharpe Ratio Rank: 8585
Sharpe Ratio Rank
ALK-B.CO Sortino Ratio Rank: 8888
Sortino Ratio Rank
ALK-B.CO Omega Ratio Rank: 8383
Omega Ratio Rank
ALK-B.CO Calmar Ratio Rank: 8282
Calmar Ratio Rank
ALK-B.CO Martin Ratio Rank: 8484
Martin Ratio Rank
GMAB
GMAB Risk / Return Rank: 5252
Overall Rank
GMAB Sharpe Ratio Rank: 5757
Sharpe Ratio Rank
GMAB Sortino Ratio Rank: 5151
Sortino Ratio Rank
GMAB Omega Ratio Rank: 4949
Omega Ratio Rank
GMAB Calmar Ratio Rank: 5252
Calmar Ratio Rank
GMAB Martin Ratio Rank: 5353
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ALK-B.CO vs. GMAB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ALK-Abelló A/S (ALK-B.CO) and Genmab A/S (GMAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

ALK-B.COGMABDifference
Sharpe ratioReturn per unit of total volatility
1.78
0.44

+1.34

Sortino ratioReturn per unit of downside risk
2.96
0.84

+2.12

Omega ratioGain probability vs. loss probability

1.33

1.10

+0.23

Calmar ratioReturn relative to maximum drawdown

3.00

0.46

+2.54

Martin ratioReturn relative to average drawdown

8.37

1.03

+7.34

Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ALK-B.CO vs. GMAB - Sharpe Ratio Comparison

The current ALK-B.CO Sharpe Ratio is 1.78, which is higher than the GMAB Sharpe Ratio of 0.44. The chart below compares the historical Sharpe Ratios of ALK-B.CO and GMAB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Sharpe Ratios by Period

ALK-B.COGMABDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.78

0.44

+1.34

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.39

-0.25

+0.65

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.45

0.07

+0.38

Sharpe Ratio (All Time)

Calculated using the full available price history

0.40

0.30

+0.10

Drawdowns

ALK-B.CO vs. GMAB - Drawdown Comparison

The maximum ALK-B.CO drawdown since its inception was -80.49%, roughly equal to the maximum GMAB drawdown of -84.57%. Use the drawdown chart below to compare losses from any high point for ALK-B.CO and GMAB.

Loading charts...

Drawdown Indicators

ALK-B.COGMABDifference

Max Drawdown

Largest peak-to-trough decline

-80.49%

-84.57%

+4.08%

Max Drawdown (1Y)

Largest decline over 1 year

-15.89%

-32.41%

+16.52%

Max Drawdown (3Y)

Largest decline over 3 years

-27.77%

-57.99%

+30.22%

Max Drawdown (5Y)

Largest decline over 5 years

-58.84%

-63.90%

+5.06%

Max Drawdown (10Y)

Largest decline over 10 years

-58.84%

-63.90%

+5.06%

Current Drawdown

Current decline from peak

-0.67%

-50.94%

+50.27%

Average Drawdown

Average peak-to-trough decline

-31.62%

-29.99%

-1.63%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.64%

14.28%

-8.64%

Volatility

ALK-B.CO vs. GMAB - Volatility Comparison

The current volatility for ALK-Abelló A/S (ALK-B.CO) is 8.61%, while Genmab A/S (GMAB) has a volatility of 12.60%. This indicates that ALK-B.CO experiences smaller price fluctuations and is considered to be less risky than GMAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

ALK-B.COGMABDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.61%

12.60%

-3.99%

Volatility (6M)

Calculated over the trailing 6-month period

18.32%

24.68%

-6.36%

Volatility (1Y)

Calculated over the trailing 1-year period

26.76%

33.53%

-6.77%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

36.65%

32.58%

+4.07%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

35.40%

34.66%

+0.74%

Dividends

ALK-B.CO vs. GMAB - Dividend Comparison

ALK-B.CO's dividend yield for the trailing twelve months is around 0.60%, while GMAB has not paid dividends to shareholders.

PositionTTM20252024202320222021202020192018201720162015
ALK-B.CO
ALK-Abelló A/S		0.60%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.68%0.54%0.57%
GMAB
Genmab A/S		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

ALK-B.CO vs. GMAB - Financials Comparison

This section allows you to compare key financial metrics between ALK-Abelló A/S and Genmab A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

Please note, different currencies. ALK-B.CO values in DKK, GMAB values in USD

Frequently Asked Questions

ALK-B.CO and GMAB have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for ALK-B.CO and GMAB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer